# cfr-section 31 CFR 598.309

IRI: <https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d>

Type: [adms:Identifier](http://www.w3.org/ns/adms#Identifier)

- `dcterms:conformsTo`: [cfr-section](https://ontology.bommaritollc.com/vocab/scheme/cfr-section)
- `prov:wasDerivedFrom`: [evidence from https://www.govinfo.gov/app/details/CFR-2025-title31-vol1](https://ontology.bommaritollc.com/id/01a0f09f-bf7d-704b-a66b-64a60eee777c)
- `skos:notation`: 31 CFR 598.309

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/CFR-2025-title31-vol1) (www.govinfo.gov)

## Pointing here

- Its identifier, from (1; `adms:identifier`):
  - [31 CFR 598.309 Narcotic drug; controlled substance; listed chemical.](https://ontology.bommaritollc.com/id/01a0f09f-bf7d-704b-a66b-64a7d234c151)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d)
Cite as: cfr-section 31 CFR 598.309. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f09f-bf7e-7142-9675-4a56bf53b17d
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
